Increased expression of annexin A1 is correlated with K-ras mutation in colorectal cancer

Tohoku Journal of Experimental Medicine

Volumn 222, Issue 4, 2010, Pages 243-250

  Su, Ning ^a   Xu, Xin Yun ^a   Chen, Han ^a   Gao, Wen Chao ^a   Ruan, Can Ping ^a   Wang, Qiang ^a   Sun, Yan Ping ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Annexin A1; Colorectal cancer; Gene expression; Gene mutation; K ras

Indexed keywords

K RAS PROTEIN; LIPOCORTIN 1; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER RISK; CARCINOGENESIS; CODON; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; MUTATIONAL ANALYSIS; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; WESTERN BLOTTING;

ANNEXIN A1; COLORECTAL NEOPLASMS; DEMOGRAPHY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MUTATION; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; RNA, MESSENGER;

EID: 78650037397     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.222.243     Document Type: Article

References (33)

1. Akkiprik, M., Ataizi-Celikel, C., Dusunceli, F., Sonmez, O., Gulluoglu, B.M., Sav, A. & Ozer, A. (2007) Clinical signif-cance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers. J. Gastrointestin. Liver Dis., 16, 11-17.
2. Alldridge, L.C. & Bryant, C.E. (2003) Annexin 1 regulates cell proliferation by disruption of cell morphology and inhibition of cyclin D1 expression through sustained activation of the ERK1/2 MAPK signal. Exp. Cell Res., 290, 93-107.
3. Alldridge, L.C., Harris, H.J., Plevin, R., Hannon, R. & Bryant, C.E. (1999) The annexin protein lipocortin 1 regulates the MAPK/ ERK pathway. J. Biol. Chem., 274, 37620-37628.
4. Andreyev, H.J., Norman, A.R., Cunningham, D., Oates, J., Dix, B.R., Iacopetta, B.J., Young, J., Walsh, T., Ward, R., Hawkins, N., Beranek, M., Jandik, P., Benamouzig, R., Jullian, E., Laurent-Puig, P., Olschwang, S., Muller, O., Hoffmann, I., Rabes, H.M., Zietz, C., Troungos, C., Valavanis, C., Yuen, S.T., Ho, J.W., Croke, C.T., O'Donoghue, D.P., Giaretti, W., Rapallo, A., Russo, A., Bazan, V., Tanaka, M., Omura, K., Azuma, T., Ohkusa, T., Fujimori, T., Ono, Y., Pauly, M., Faber, C., Glaesener, R., de Goeij, A.F., Arends, J.W., Andersen, S.N., Lovig, T., Breivik, J., Gaudernack, G., Clausen, O.P., De Angelis, P.D., Meling, G.I., Rognum, T.O., Smith, R., Goh, H.S., Font, A., Rosell, R., Sun, X.F., Zhang, H., Benhattar, J., Losi, L., Lee, J.Q., Wang, S.T., Clarke, P.A., Bell, S., Quirke, P., Bubb, V.J., Piris, J., Cruickshank, N.R., Morton, D., Fox, J.C., Al-Mulla, F., Lees, N., Hall, C.N., Snary, D., Wilkinson, K., Dillon, D., Costa, J., Pricolo, V.E., Finkelstein, S.D., Thebo, J.S., Senagore, A.J., Halter, S.A., Wadler, S., Malik, S., Krtolica, K. & Urosevic, N. (2001) Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br. J. Cancer, 85, 692-696.
5. Bazan, V., Migliavacca, M., Zanna, I., Tubiolo, C., Grassi, N., Latteri, M.A., La Farina, M., Albanese, I., Dardanoni, G., Salerno, S., Tomasino, R.M., Labianca, R., Gebbia, N. & Russo, A. (2002) Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype. Ann. Oncol., 13, 1438-1446.
6. Bokemeyer, C., Bondarenko, I., Makhson, A., Hartmann, J.T., Aparicio, J., de Braud, F., Donea, S., Ludwig, H., Schuch, G., Stroh, C., Loos, A.H., Zubel, A. & Koralewski, P. (2009) Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer. J. Clin. Oncol., 27, 663-671.
7. Brink, M., Weijenberg, M.P., de Goeij, A.F., Roemen, G.M., Lentjes, M.H., de Bruine, A.P., Goldbohm, R.A. & van den Brandt, P.A. (2005) Meat consumption and K-ras mutations in sporadic colon and rectal cancer in The Netherlands Cohort Study. Br. J. Cancer, 92, 1310-1320.
8. Burt, R.W., Barthel, J.S., Dunn, K.B., David, D.S., Drelichman, E., Ford, J.M., Giardiello, F.M., Gruber, S.B., Halverson, A.L., Hamilton, S.R., Ismail, M.K., Jasperson, K., Lazenby, A.J., Lynch, P.M., Martin, E.W. Jr., Mayer, R.J., Ness, R.M., Provenzale, D., Rao, M.S., Shike, M., Steinbach, G., Terdiman, J.P. & Weinberg, D. (2010) NCCN clinical practice guidelines in oncology. Colorectal cancer screening. J. Natl. Compr. Canc. Netw., 8, 8-61.
9. Croxtall, J.D. & Flower, R.J. (1992) Lipocortin 1 mediates dexa-methasone-induced growth arrest of the A549 lung adenocarci-noma cell line. Proc. Natl. Acad. Sci. USA, 89, 3571-3575.
10. Cui, B., Johnson, S.P., Bullock, N., Ali-Osman, F., Bigner, D.D. & Friedman, H.S. (2009) Bifunctional DNA alkylator 1,3-bis (2-chloroethyl)-1-nitrosourea activates the ATR-Chk1 pathway independently of the mismatch repair pathway. Mol. Pharmacol., 75, 1356-1363.
11. de Graauw, M., van Miltenburg, M.H., Schmidt, M.K., Pont, C., Lalai, R., Kartopawiro, J., Pardali, E., Le Devedec, S.E., Smit, V.T., van der Wal, A., Van't Veer, L.J., Cleton-Jansen, A.M., ten Dijke, P. & van de Water, B. (2010) Annexin A1 regulates TGF-beta signaling and promotes metastasis formation of basal-like breast cancer cells. Proc. Natl. Acad. Sci. USA, 107, 6340-6345.
12. Duncan, R., Carpenter, B., Main, L.C., Telfer, C. & Murray, G.I. (2008) Characterisation and protein expression profiling of annexins in colorectal cancer. Br. J. Cancer, 98, 426-433.
13. Falini, B., Tiacci, E., Liso, A., Basso, K., Sabattini, E., Pacini, R., Foa, R., Pulsoni, A., Dalla Favera, R. & Pileri, S. (2004) Simple diagnostic assay for hairy cell leukaemia by immuno-cytochemical detection of annexin A1 (ANXA1). Lancet, 363, 1869-1870.
14. Fearon, E.R. (1994) Molecular genetic studies of the adenoma-carcinoma sequence. Adv. Intern. Med., 39, 123-147.
15. Fearon, E.R. & Vogelstein, B. (1990) A genetic model for colorectal tumorigenesis. Cell, 61, 759-767.
16. Futter, C.E., Felder, S., Schlessinger, J., Ullrich, A. & Hopkins, C.R. (1993) Annexin I is phosphorylated in the multivesicular body during the processing of the epidermal growth factor receptor. J. Cell Biol., 120, 77-83.
17. Gerke, V. & Moss, S.E. (2002) Annexins: from structure to function. Physiol. Rev., 82, 331-371.
18. He, Z.Y., Wen, H., Shi, C.B. & Wang, J. (2010) Up-regulation of hnRNP A1, Ezrin, tubulin beta-2C and Annexin A1 in sentinel lymph nodes of colorectal cancer. World J. Gastroenterol., 16, 4670-4676.
19. Hippo, Y., Yashiro, M., Ishii, M., Taniguchi, H., Tsutsumi, S., Hirakawa, K., Kodama, T. & Aburatani, H. (2001) Differential gene expression profles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res., 61, 889-895.
20. Karapetis, C.S., Khambata-Ford, S., Jonker, D.J., O'Callaghan, C.J., Tu, D., Tebbutt, N.C., Simes, R.J., Chalchal, H., Shapiro, J.D., Robitaille, S., Price, T.J., Shepherd, L., Au, H.J., Langer, C., Moore, M.J. & Zalcberg, J.R. (2008) K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N. Engl. J. Med., 359, 1757-1765.
21. Li, C.F., Shen, K.H., Huang, L.C., Huang, H.Y., Wang, Y.H. & Wu, T.F. (2009) Annexin-I overexpression is associated with tumour progression and independently predicts inferior disease-specifc and metastasis-free survival in urinary bladder urothelial carcinoma. Pathology, 42, 43-49.
22. Packham, D., Ward, R.L., Ap Lin, V., Hawkins, N.J. & Hitchins, M.P. (2009) Implementation of novel pyrosequencing assays to screen for common mutations of BRAF and KRAS in a cohort of sporadic colorectal cancers. Diagn Mol. Pathol., 18, 62-71.
23. Perretti, M. & Gavins, F.N. (2003) Annexin 1: an endogenous anti-infammatory protein. News Physiol. Sci., 18, 60-64.
24. Porebska, I., Harlozinska, A. & Bojarowski, T. (2000) Expression of the tyrosine kinase activity growth factor receptors (EGFR, ERB B2, ERB B3) in colorectal adenocarcinomas and adenomas. Tumour Biol., 21, 105-115.
25. Sameer, A.S., Chowdhri, N.A., Abdullah, S., Shah, Z.A. & Siddiqi, M.A. (2009) Mutation pattern of K-ras gene in colorectal cancer patients of Kashmir: a report. Indian J. Cancer, 46, 219-225.
26. Samowitz, W.S., Curtin, K., Schaffer, D., Robertson, M., Leppert, M. & Slattery, M.L. (2000) Relationship of Ki-ras mutations in colon cancers to tumor location, stage, and survival: a population-based study. Cancer Epidemiol. Biomarkers Prev., 9, 1193-1197.
27. Shen, D., Nooraie, F., Elshimali, Y., Lonsberry, V., He, J., Bose, S., Chia, D., Seligson, D., Chang, H.R. & Goodglick, L. (2006) Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis. Hum. Pathol., 37, 1583-1591.
28. Shirasawa, S., Furuse, M., Yokoyama, N. & Sasazuki, T. (1993) Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science, 260, 85-88.
29. Sobin, L.H. & Wittekind, C. (1997) UICC TNM classifcation of malignant tumors. Wiley, New York.
30. Vogelstein, B., Fearon, E.R., Hamilton, S.R., Kern, S.E., Preisinger, A.C., Leppert, M., Nakamura, Y., White, R., Smits, A.M. & Bos, J.L. (1988) Genetic alterations during colorectal-tumor development. N. Engl. J. Med., 319, 525-532.
31. Wei, S., Liang, Z., Gao, J., Wu, S., Zhu, H., Liu, H. & Liu, T. (2005) Patterns of K-ras codon 12 and 13 mutations found in pancreatic adenocarcinoma of 30 Chinese patients by micro-dissection, PCR and direct sequencing. J. Gastroenterol. Hepatol., 20, 67-72.
32. White, I.J., Bailey, L.M., Aghakhani, M.R., Moss, S.E. & Futter, C.E. (2006) EGF stimulates annexin 1-dependent inward vesiculation in a multivesicular endosome subpopulation. EMBO J., 25, 1-12.
33. Yi, M. & Schnitzer, J.E. (2009) Impaired tumor growth, metastasis, angiogenesis and wound healing in annexin A1-null mice. Proc. Natl. Acad. Sci. USA, 106, 17886-17891.